This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mirkin, S. Articles by Oehninger, S. Search for Related Content PubMed PubMed Citation Articles by Mirkin, S. Articles by Oehninger, S.

Gene Expression Profiles and Structural/Functional Features of the Peri-Implantation Endometrium in Natural and Gonadotropin-Stimulated Cycles

The Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology (S.M., J.-G.H., S.O.) and Department of Pathology (J.D.), Eastern Virginia Medical School, Norfolk, Virginia 23507; and Second Department of Obstetrics and Gynecology (G.N.), Aretaieio University Hospital, Athens 16675, Greece

Address all correspondence and requests for reprints to: Sergio Oehninger, M.D., Ph.D., The Jones Institute for Reproductive Medicine, 601 Colley Avenue, Norfolk, Virginia 23507. E-mail:oehninsc{at}evms.edu.

It has been speculated that controlled ovarian hyperstimulation (COH), as performed during in vitro fertilization therapy, may negatively affect embryo implantation. The objective of this prospective and randomized study was to investigate gene expression profiles of the human endometrium during the window of implantation of gonadotropin-stimulated COH cycles compared with temporally matched natural cycles (d 21). Analysis was performed with high-density oligonucleotide microarrays. In addition, other structural and functional features of the endometrium were investigated. Results corroborated that COH cycles depicted advancement of pinopodes appearance, histological features, and steroid receptor down-regulation when compared with natural cycles. These changes were associated with significant, albeit small, variations in gene expression (18 genes/expressed sequence tags and –1.55- to +3.40-fold changes). Second, there were significant changes in gene expression when comparing cycles using a GnRH agonist vs. a GnRH antagonist (13 genes/expressed sequence tags and +1.42- to +2.10-fold changes). This is the first attempt to elucidate gene expression profiles of the endometrium during COH cycles. The observed differences in gene expression in COH cycles using state-of-the-art protocols may not have a major functional impact on embryo implantation.

This article has been cited by other articles:

				A. Franchi, J. Zaret, X. Zhang, S. Bocca, and S. Oehninger Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium Mol. Hum. Reprod., July 1, 2008; 14(7): 413 - 421. [Abstract] [Full Text] [PDF]

				H.-F. Xia, J. Sun, Q.-H. Sun, Y. Yang, and J.-P. Peng Implantation-associated gene-1 (Iag-1): a novel gene involved in the early process of embryonic implantation in rat Hum. Reprod., July 1, 2008; 23(7): 1581 - 1593. [Abstract] [Full Text] [PDF]

				N. S. Macklon, M. H. van der Gaast, A. Hamilton, B. C. J. M. Fauser, and L. C. Giudice The Impact of Ovarian Stimulation With Recombinant FSH in Combination With GnRH Antagonist on the Endometrial Transcriptome in the Window of Implantation Reproductive Sciences, April 1, 2008; 15(4): 357 - 365. [Abstract] [PDF]

				J.A. Horcajadas, A. Pellicer, and C. Simon Wide genomic analysis of human endometrial receptivity: new times, new opportunities Hum. Reprod. Update, January 1, 2007; 13(1): 77 - 86. [Abstract] [Full Text] [PDF]

				H.-C. Ruan, X.-M. Zhu, Q. Luo, A.-X. Liu, Y.-L. Qian, C.-Y. Zhou, F. Jin, H.-F. Huang, and J.-Z. Sheng Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice Hum. Reprod., October 1, 2006; 21(10): 2521 - 2529. [Abstract] [Full Text] [PDF]

				R. L. Kelley, K. L. Kind, M. Lane, R. L. Robker, J. G. Thompson, and L. J. Edwards Recombinant human follicle-stimulating hormone alters maternal ovarian hormone concentrations and the uterus and perturbs fetal development in mice Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E761 - E770. [Abstract] [Full Text] [PDF]

				T. Strowitzki, A. Germeyer, R. Popovici, and M. von Wolff The human endometrium as a fertility-determining factor Hum. Reprod. Update, September 1, 2006; 12(5): 617 - 630. [Abstract] [Full Text] [PDF]

				J. A. Horcajadas, A. M. Sharkey, R. D. Catalano, J. R. A. Sherwin, F. Dominguez, L. A. Burgos, A. Castro, M. R. Peraza, A. Pellicer, and C. Simon Effect of an Intrauterine Device on the Gene Expression Profile of the Endometrium J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3199 - 3207. [Abstract] [Full Text] [PDF]

				N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF]

				S. Mirkin, M. Arslan, D. Churikov, A. Corica, J.I. Diaz, S. Williams, S. Bocca, and S. Oehninger In search of candidate genes critically expressed in the human endometrium during the window of implantation Hum. Reprod., August 1, 2005; 20(8): 2104 - 2117. [Abstract] [Full Text] [PDF]

				C. A White and L. A Salamonsen A guide to issues in microarray analysis: application to endometrial biology Reproduction, July 1, 2005; 130(1): 1 - 13. [Abstract] [Full Text] [PDF]